The Effects of Adrenoceptor and Adrenergic Blocking Drugs on Plasma Lipoproteins

  • A. Lehtonen
Conference paper
Part of the Proceedings in Life Sciences book series (LIFE SCIENCES)


The catecholamines synthesized and secreted by the adrenal medulla regulate a wide spectrum of metabolic processes. Glugoneogenesis, glycogenosis and lipolysis, for example, are strongly influenced by catecholamines.


Beta Blocker Lipoprotein Lipase Plasma Lipoprotein Total Plasma Cholesterol Intrinsic Sympathomimetic Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Day JL, Metcalfe J, Simpson CN (1982) Adrenergic mechanisms in control of plasma lipid concentrations. Br Med J 284:1145–1148CrossRefGoogle Scholar
  2. Lehtonen A (1984) The effect of acebutolol on plasma lipids, blood glucose and serum insulin levels. Acta Med Scand 216:57–60PubMedCrossRefGoogle Scholar
  3. Lehtonen A, Marniemi J (1984) Effect of atenolol on plasma HDL-cholesterol subfractions. Atherosclerosis 51:335–338PubMedCrossRefGoogle Scholar
  4. Lehtonen A, Viikari J (1979) Long-term effect of sotalol on plasma lipids. Clin Sci 57 (Suppl): 405–407Google Scholar
  5. Lehtonen A, Hietanen E, Marniemi J, Peltonen P, Niskanen J (1982) Effect of pinodolol on serum lipids and lipid metabolizing enzymes. Br J Clin Pharmacol 13 (Suppl 2):445–447Google Scholar
  6. Lehtonen A, Himanen P, Saraste M, Niittymäki K, Marniemi J (1986) Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins. Br J Clin Pharmacol 21:77–81Google Scholar
  7. Leren P, Helgeland A, Holme I, Foss OP, Hjermann I, Lund-Larsen PG (1980) Effect of propranolol and prazosin on blood lipids. The Oslo study. Lancet ii:4–6CrossRefGoogle Scholar
  8. Sacks FM, Dzau VJ (1986) Adrenergic effects on plasma lipoprotein metabolism. Speculation on mechanisms of action. Am J Med 80 (Suppl 2A):71–81PubMedCrossRefGoogle Scholar
  9. Sihiff H, Weidmann P, Mordasini R, Riesen W, Bachmann C (1982) Reversal of diuretic-induced increases in serum low-density lipoprotein cholesterol by the beta-blocker pindolol. Metabolism 31:411–416CrossRefGoogle Scholar
  10. Välimäki M, Maass L, Harno K, Nikkilä EA (1986) Lipoprotein lipids and apoproteins during beta-blocker administration: comparison of penbutolol and atenolol. Eur J Clin Pharmacol 30:17–20PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • A. Lehtonen
    • 1
  1. 1.Department of MedicineTurku City HospitalTurkuFinland

Personalised recommendations